2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

MAY 22 Posters Sunday Morning PO-156: PO-157: Amlodipine/Valsartan Single Pill Combination Treatment of Arterial Hypertension in a Real Life Practice in Russia Irina E. Chazova, 1 Yuri A. Karpov, 1 Alexey V. Vigdorchik†, 2 Antonina Y. Zazulina. 2 1 Russian Cardiology Scientific-Industrial Complex, Moscow, RU; 2 Novartis Pharma LLC, Moscow, RU. Real Life Safety and Effectiveness of Amlodipine/ Valsartan Single Pill Combination in the Treatment of Hypertension Irina E. Chazova, 1 Neelesh Dongre, 2 Alexey V. Vigdorchik†. 3 1 Russian Cardiology Scientific-Industrial Complex, Moscow, RU; 2 Novartis Pharma AG, Basel, CH; 3 Novartis Pharma LLC, Moscow, RU. Clinical Trials PO-158: PO-159: PO-160: PO-161: PO-162: The Influence of Antihypertensive Therapy on Blood Pressure Variability: The X-CELLENT Study Yi Zhang, 1,2 Davide Agnoletti, 1 Michel E. Safar, 1 Jacques Blacher. 1 1 Paris Descartes University, Paris, FR; 2 Jiaotong University School of Medicine, Shanghai, CN. A Double-Dummy Comparison of De Novo Combination vs Sequential Add-On Therapy: ‘ACCELERATE’ Morris Brown, 1,2 Gordon McInnes, 1,3 Cheraz Cherif Papst, 4 Jack Zhang, 4 Thomas MacDonald. 1,5 1 British Hypertension Society, GB; 2 University of Cambridge, GB; 3 University of Glasgow, GB; 4 Novartis Pharma AG, CH; 5 University of Dundee, GB. Amlodipine Plus Telmisartan or Amiloride for Hypertensive Patients: Focus on Effects on Metabolic Profiles Hong Yuan, Jingjing Cai, Zhijun Huang. The Center of Clinical Pharmacology of the Third Xiangya Hospital, Central South University, Changsha, CN. Amlodipine Plus Telmisartan or Amiloride for Hypertension in Moderate and High-Risk Patients: A 24-Week Observation Jingjing Cai, Zhijun Huang, Rong Cui, Hong Yuan. The Center of Clinical Pharmacology of the Third Xiangya Hospital, Central South University, Changsha, CN. Efficacy and Safety of Azilsartan Medoxomil/ Chlorthalidone vs Olmesartan/HCTZ Combinations in Stage 2 Systolic HTN William C. Cushman†, 1 Domenic Sica, 2 George L. Bakris, 3 Michael A. Weber, 4 William B. White, 5 Charlie Cao, 6 Andrew Roberts, 6 Stuart Kupfer. 6 1 U of TN College of Medicine, Memphis, TN, US; 2 VA Commonwealth U Health System, Richmond, VA, US; 3 U of Chicago Pritzker School of Medicine, Chicago, IL, US; 4 New York, NY, US; 5 U of CT School of Medicine, Farmington, CT, US; 6 Takeda Global Research & Development, Deerfield, IL, US. 112
Sunday Morning MAY 22 Posters PO-163: Effect of Aliskiren and Antihypertensive Drugs on Diastolic Function in Hypertensives with Diastolic Dysfunction: A Randomised Study Maria Leonarda De Rosa. University of Naples Federico II, Naples, IT. PO-164: Effects of Add-On Nebivolol on Blood Pressure and Glucose Parameters in Hypertensive Patients with Prediabetes P. Deedwania†, 1 D. G. Cheung, 2 J. Shea, 3 W. Chen, 3 J. J. Whalen. 3 1 UCSF, US; 2 Long Beach Center for Clinical Research, US; 3 Forest Research Institute, US. PO-165: Incident Diabetes with Antihypertensive Drugs: Updated Network and Bayesian Meta-Analyses of Clinical Trial Data William J. Elliott†, 1 Sanjib Basu, 2 Peter M. Meyer. 2 1 Pacific Northwest University of Health Sciences, Yakima, WA, US; 2 RUSH Medical College, Chicago, IL, US. PO-166: Efficacy and Safety of Combination DRI/CCB (± Diuretic) in US Minority Patients with Stage 2 Hypertension and Obesity Keith C. Ferdinand†, 1 Richard Weitzman, 2 Das Purkayastha, 2 Kanaka Sridharan, 2 Edgar A. Jaimes. 3 1 Emory University, Atlanta, GA, US; 2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, US; 3 The University of Alabama at Birmingham, Birmingham, AL, US. PO-167: Efficacy of Combination Aliskiren/Amlodipine with and without Diuretic on Ambulatory Blood Pressure in Minorities with Hypertension Keith C. Ferdinand†, 1 Richard Weitzman, 2 Das Purkayastha, 2 Kanaka Sridharan, 2 Edgar A. Jaimes. 3 1 Emory University, Atlanta, GA, US; 2 Novartis Pharmaceuticals Corp, East Hanover, NJ, US; 3 The University of Alabama at Birmingham, Birmingham, AL, US. PO-168: Role of Plasma Renin Activity on BP Response to Aliskiren-Based Therapy in Stage 2 Hypertensive African Americans Keith C. Ferdinand†, 1 Richard Weitzman, 2 Das Purkayastha, 2 Kanaka Sridharan, 2 Edgar A. Jaimes. 3 1 Emory University, Atlanta, GA, US; 2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, US; 3 The University of Alabama at Birmingham, Birmingham, AL, US. PO-169: Efficacy and Safety of Combination DRI/CCB (±Diuretic) Therapy in African Americans with Stage 2 Hypertension Keith C. Ferdinand†, 1 Richard Weitzman, 2 Das Purkayastha, 2 Kanaka Sridharan, 2 Edgar A. Jaimes. 3 1 Emory University, Atlanta, GA, US; 2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, US; 3 The University of Alabama at Birmingham, Birmingham, AL, US. 113
Page 1 and 2:
American Society of Hypertension, I
Page 3:
Visit booth #1100 to find out more
Page 6 and 7:
Past Presidents of the American Soc
Page 8 and 9:
Program Color Key The pages of this
Page 10 and 11:
Letter continued Following the Awar
Page 12 and 13:
General Information continued Discl
Page 14 and 15:
General Information continued ASH S
Page 16 and 17:
General Information continued ASH P
Page 18 and 19:
2011 ASH Corporate Members Boehring
Page 20 and 21:
ASH Leadership 2010-2011 Board of D
Page 22 and 23:
Special Lecture Monday, May 23, 201
Page 24 and 25:
Young Scholar Award* Monday, May 23
Page 26 and 27:
Special Lecture Monday, May 23, 201
Page 28 and 29:
2011 Abstract Reviewers Lawrence J.
Page 30 and 31:
More than half of hypertensive pati
Page 32 and 33:
Poster Category Presentation Poster
Page 34 and 35:
2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37:
2011 ASH Faculty continued David L.
Page 38 and 39:
American Society of Hypertension, I
Page 40 and 41:
Program Color Key The pages of this
Page 42 and 43:
MAY 21 Saturday Morning Hypertensio
Page 44 and 45:
MAY 21 Sessions Saturday Afternoon
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
MAY 21 Posters Saturday Evening Pos
Page 52 and 53:
MAY 22 Sunday morning Sessions cont
Page 54 and 55:
MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57:
MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59:
MAY 22 Debates Sunday Morning 11:00
Page 60 and 61:
MAY 22 Plenary Session I Sunday Aft
Page 62 and 63:
MAY 22 Special Sessions Sunday Afte
Page 64 and 65: MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67: MAY 23 Satellite Symposium 6:00 AM
Page 68 and 69: MAY 23 Sessions Monday morning 8:00
Page 78 and 79: MAY 23 Plenary Session II Monday Af
Page 80 and 81: MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83: MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85: MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88: 2011 American Society of Hypertensi
Page 89 and 90: Saturday Afternoon MAY 21 Posters 4
Page 91 and 92: Saturday Afternoon MAY 21 Posters P
Page 93 and 94: Saturday Afternoon MAY 21 Posters E
Page 99 and 100: Saturday Afternoon MAY 21 Posters I
Page 107 and 108: Sunday Morning MAY 22 Posters 10:00
Page 109 and 110: Sunday Morning MAY 22 Posters 10:00
Page 111 and 112: Sunday Morning MAY 22 Posters PO-13
Page 113: Sunday Morning MAY 22 Posters PO-14
Page 127 and 128: Monday Morning Afternoon MAY 21 23
Page 147 and 148: Faculty Disclosure Listing Rajiv Ag
Page 149 and 150: Faculty Disclosure Listing continue
Page 157 and 158: ASH Hypertension Resource Pavilion
Page 159 and 160: 2011 ASH Innovations Theater Rhinel
Page 161 and 162: 2011 ASH Exhibitors continued A & D
Page 163 and 164: 2011 ASH Exhibitors continued David
Page 165 and 166:
2011 ASH Exhibitors continued Inter
Page 167 and 168:
2011 ASH Exhibitors continued Novar
Page 169 and 170:
2011 ASH Exhibitors continued Wiley
Page 171 and 172:
Author Index Berezina, Aelita V., 8
Page 173 and 174:
Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176:
Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178:
Author Index Makani, Harikrishna, 1
Page 179 and 180:
Author Index Rabelink, Ton J., 93 R
Page 181 and 182:
Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184:
Hilton New York Floor Plans Second
Page 185 and 186:
Hilton New York Floor Plans Fourth
Page 187 and 188:
Tekamlo (aliskiren and amlodipine)
Page 189 and 190:
25% (systolic) and 27% (diastolic)
Page 191 and 192:
Two cases of angioedema with respir
Page 193 and 194:
amlodipine and sildenafil were used
Page 195 and 196:
Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?